Is PubMed Hurting Scientific Journals?

A study concludes that the open access repository is decreasing biomedical journal readership.

Written byKate Yandell
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, TOBIAS M. ECKRICHIn 2008 the National Institutes of Health (NIH) began mandating that all of the research the agency funded be publicly available within a year and deposited in the online repository PubMed Central (PMC). Now PMC is taking away traffic from journal websites, according to a new study published in The FASEB Journal, even when the journals also provide the articles for free.

The paper’s author, Philip Davis, who runs his own consulting company in Ithaca, New York, did a case-control study, analyzing PDF and HTML article downloads taking place between February 2008 and January 2011 from 14 biomedical research journals. He compared “cases”—NIH-funded articles that became free both on PMC and on the journal websites—with “controls”—articles not funded by the NIH, which the journals made freely available after a year on their website but did not post to PMC—and found that articles posted on PMC received 21.4 percent fewer HTML downloads from the journal websites than the articles not available on PMC, and 13.8 percent fewer PDF downloads

The NIH’s open access policy has been hailed as one that gives taxpayers access to research they have paid ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform